The Galleri® Community Research Program
Part of paid clinical trials in Menlo Park, California.
- Sponsor
- GRAIL, Inc.
- Study ID
- NCT06603259
- Status
- Enrolling By Invitation
Conditions
- Data Collection
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
GRAIL, the company that developed the Galleri test and is sponsoring this study, would like to learn more from individuals who have received the Galleri multi-cancer early detection test. The purpose of this study is to understand how health information can be accurately collected from the medical records of individuals who have received the Galleri test in a real world setting. The collected information may include relevant medical and cancer history, diagnostic test results, including the Galleri test result. This will help GRAIL build a future larger study for individuals who have taken the Galleri test. This future study is important for understanding patient journeys after a Galleri test (including any diagnostic testing done and any diagnoses made), for improving the Galleri test, and to contribute to other research on cancer screening.
Key Dates
- Start date
- Aug 19, 2024
- Status verified
- Sep 2024
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 250 participants (estimated)
Primary Outcome Measure
Quality of data retrieved from participants who have received the Galleri test [ Time Frame: From enrollment to the the end of study (12 month study participation period), data will be retrieved and assessed for this measure. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| GRAIL | Menlo Park | California | 94025 | - |